ANI Pharmaceuticals, Inc.
NASDAQ: ANIP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Nikhil Lalwani
- Employees
- 970
- Headquarters
- Baudette, United States
- IPO year
- 2000
- Market cap
- $1.9B
- Website
- https://www.anipharmaceuticals.com
Loading ANIP…
Loading profile data…Frequently asked questions about ANIP
What does ANI Pharmaceuticals, Inc. (ANIP) do?
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids...
Where does ANIP trade?
ANI Pharmaceuticals, Inc. (ANIP) trades on the NASDAQ.
What sector is ANIP in?
ANI Pharmaceuticals, Inc. (ANIP) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of ANI Pharmaceuticals, Inc.?
Nikhil Lalwani is the chief executive officer of ANI Pharmaceuticals, Inc. (ANIP).
Where is ANI Pharmaceuticals, Inc. headquartered?
ANI Pharmaceuticals, Inc. is headquartered in United States.
Does ANIP pay a dividend?
ANI Pharmaceuticals, Inc. (ANIP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ANIP go public?
ANI Pharmaceuticals, Inc. (ANIP) completed its initial public offering in 2000.